Osteogenex, Inc.

Kansas city, KS 66103

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.63MM
First Award Date 06/12/06
Most Recent Award Date 05/09/13

Key Personnel

Last Name Name Awards Contact
Ellies Debra L Ellies 4

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 05/09/13 - 02/08/14

DESCRIPTION (provided by applicant): The osteoporosis market is still in demand for new therapeutics due to the lack of safe orally available bone building drugs. Currently, parathyroid hormone (PTH;FORTEOTM) and its analogs are the only bone building therapies available yet they capture only 8% of the osteoporosis market due to significant dosi...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-049
Budget: 09/01/09 - 08/31/11

DESCRIPTION (provided by applicant): OsteoGeneX is developing a therapeutic directed against the new bone target Sclerostin (SOST) for the treatment of osteoporosis and related bone disorders. Through genomic approaches Sclerostin was identified as a master regulator of bone mass affecting men and women. Using proteomic approaches Dr. Ellies &K...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-49
Budget: 09/01/08 - 08/31/09

DESCRIPTION (provided by applicant): OsteoGeneX is developing a therapeutic directed against the new bone target Sclerostin (SOST) for the treatment of osteoporosis and related bone disorders. Through genomic approaches Sclerostin was identified as a master regulator of bone mass affecting men and women. Using proteomic approaches Dr. Ellies & ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/12/06 - 09/30/07

DESCRIPTION (provided by applicant): Osteoporosis affects 55% of Americans over the age of 50, and incurs a medical cost of $47 million a day. It is caused by a disruption in the fine equilibrium between bone resorption and bone deposition. Currently, the most successful pharmaceutical drugs for osteoporosis target bone resorption only, i.e. Oes...